A human-like fibronectin and its dermal filling composition
By preparing human-like fibronectin and its dermal filler composition, the biocompatibility and durability issues of traditional dermal fillers have been solved, achieving a highly effective improvement in skin wrinkles and demonstrating significant medical and cosmetic applications.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- JILIN PROVINCE LANPU HAOYE TECH CO LTD
- Filing Date
- 2026-02-12
- Publication Date
- 2026-06-19
AI Technical Summary
Traditional dermal fillers have limitations in terms of biocompatibility, durability, and ability to promote tissue regeneration, making them difficult to effectively improve skin wrinkles.
Human-derived fibronectin and its dermal filler composition are used, including human-derived fibronectin, human-derived collagen, sodium hyaluronate and pharmaceutical excipients. Human-derived fibronectin is prepared by genetic engineering and combined with other ingredients to form a dermal filler with high biocompatibility and long-term support.
It provides long-term support to skin tissue, significantly improves skin wrinkles caused by external environmental factors and age, and has important medical and cosmetic application value.
Smart Images

Figure CN121673396B_ABST